Silvia Berti

Learn More
The ever-increasing availability of new types of devices raises a number of issues for user interface designers and interactive software developers. We have designed and developed a model-based authoring environment (TERESA), which provides support when designing and developing interfaces accessible through various device types in Web-based environment.
The purpose of this paper is to report on the use of XML languages to support the TERESA tool. This is a tool for model-based design of multi-device interfaces. It considers three levels of abstractions (task model, abstract user interface and concrete user interface). For each of them a specific language has been defined and used. In addition, since the(More)
The increasing availability of various types of interactive platforms has raised the need for design environments able to support development of user interfaces that exploit interaction modalities other than the traditional graphical interfaces. In this paper we present a model-based solution to help designers in the development of voice applications. In(More)
This paper presents our solution to supporting runtime migration of Web application interfaces among devices offering different interaction modalities, in particular graphic to vocal platform migration and vice versa. Migrating between platforms implies keeping track of the user interactions in order to retrieve the runtime state of the interface and(More)
BACKGROUND Urinary microscopy is difficult to teach. This paper describes a 1-day course on urine microscopy, which was based on both theoretical and practical sessions at the microscope, during which real urine samples were examined. METHODS The course was based on: a) an introductory presentation with slides on the main components of urinary sediments(More)
BACKGROUND The independent prognostic impact of diabetes mellitus (DM) and prediabetes mellitus (pre-DM) on survival outcomes in patients with chronic heart failure has been investigated in observational registries and randomized, clinical trials, but the results have been often inconclusive or conflicting. We examined the independent prognostic impact of(More)